Skip to main content
. Author manuscript; available in PMC: 2015 Nov 10.
Published in final edited form as: J Clin Psychopharmacol. 2012 Oct;32(5):630–636. doi: 10.1097/JCP.0b013e3182676956

FIGURE 1.

FIGURE 1

Survival curve: Kaplan-Meier survival functions for naltrexone (solid line) and placebo (dotted line) groups. The naltrexone group had significantly better survival (not smoking for seven days on a row and not smoking in one day on each of two consecutive weeks) than the placebo group (Wilcoxon-Breslow test).